Opposing effects of prednisolone treatment on T/NKT cell- and hepatotoxin-mediated hepatitis in mice.
about
Therapy for alcoholic liver diseaseAnimals models of gastrointestinal and liver diseases. Animal models of alcohol-induced liver disease: pathophysiology, translational relevance, and challengesChemokines and alcoholic hepatitis: are chemokines good therapeutic targets?New drug targets for alcoholic liver disease.Combination therapy: New hope for alcoholic hepatitis?Severe alcoholic hepatitis-current concepts, diagnosis and treatment options.Diminution of hepatic response to 7, 12-dimethylbenz(α)anthracene by ethyl acetate fraction of Acacia catechu willd. through modulation of xenobiotic and anti-oxidative enzymes in rats.Combination of double negative T cells and anti-thymocyte serum reverses type 1 diabetes in NOD miceEnterogenous bacterial glycolipids are required for the generation of natural killer T cells mediated liver injuryImmune cells in liver regeneration.Alcoholic hepatitis: Translational approaches to develop targeted therapies.Glucocorticoids Have Opposing Effects on Liver Fibrosis in Hepatic Stellate and Immune CellsTargeting inflammation for the treatment of alcoholic liver disease.CD24 aggravates acute liver injury in autoimmune hepatitis by promoting IFN-γ production by CD4(+) T cells.Reversal of murine alcoholic steatohepatitis by pepducin-based functional blockade of interleukin-8 receptorsGutuo Jiejiu decoction improves survival of patients with severe alcoholic hepatitis: A retrospective cohort studyBaseline urine metabolic phenotype in patients with severe alcoholic hepatitis and its association with outcome.
P2860
Q28658193-078DAB78-0C9E-4EDF-A9E3-F90B537896A2Q33626594-A4DE5E76-9F3A-4C45-9450-864A6E243292Q33746502-9EA4D0FA-1622-45AB-A7DC-BB398329D3E4Q33746508-3F05D771-48D1-437A-9B0B-7C833D1714A6Q33746519-8E2A8B87-75B9-488E-9303-70EDDF4BE65EQ34404386-ED6C6816-B58D-4022-AC39-6E317FACD36AQ35108644-323EFD27-3E69-4840-9D3E-C63A18938F60Q36611514-14B18440-A1A1-41F4-81CE-5A0CB6C037FDQ37399621-72C53AA8-7EC6-41DB-9896-522AD887CA05Q37709524-790E6138-AA56-43D2-A81C-795E221956BFQ38759707-48579121-A3C9-41B1-A5CE-FBBEA7D01D3AQ38761023-C178C2F5-E56F-4317-9BFF-3F0F900DD00EQ39392481-18369645-5CCB-4A96-9C3F-D70197B0A2DBQ40390137-7FA8BD18-3F18-448D-9FA6-3A0542159C88Q41151392-8E772466-25F4-4BBB-8FA0-1B139AC80AB8Q42289864-F1E929DC-86ED-4AE8-99B1-4026AB1070B8Q55019089-E6E22E8E-50CB-4135-8EB4-99A7A8A7BFF3
P2860
Opposing effects of prednisolone treatment on T/NKT cell- and hepatotoxin-mediated hepatitis in mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Opposing effects of prednisolo ...... in-mediated hepatitis in mice.
@en
Opposing effects of prednisolo ...... in-mediated hepatitis in mice.
@nl
type
label
Opposing effects of prednisolo ...... in-mediated hepatitis in mice.
@en
Opposing effects of prednisolo ...... in-mediated hepatitis in mice.
@nl
prefLabel
Opposing effects of prednisolo ...... in-mediated hepatitis in mice.
@en
Opposing effects of prednisolo ...... in-mediated hepatitis in mice.
@nl
P2093
P2860
P356
P1433
P1476
Opposing effects of prednisolo ...... in-mediated hepatitis in mice.
@en
P2093
Dechun Feng
Young-Suk Won
P2860
P304
P356
10.1002/HEP.26748
P407
P577
2014-01-21T00:00:00Z